112 related articles for article (PubMed ID: 21353726)
1. Paraneoplastic cerebellar degeneration and anti-Yo antibodies.
Bataller L; Fages E; Alberola C
Neurologia; 2011 Jun; 26(5):e3-4. PubMed ID: 21353726
[No Abstract] [Full Text] [Related]
2. Anti-Yo antibody uptake and interaction with its intracellular target antigen causes Purkinje cell death in rat cerebellar slice cultures: a possible mechanism for paraneoplastic cerebellar degeneration in humans with gynecological or breast cancers.
Greenlee JE; Clawson SA; Hill KE; Wood B; Clardy SL; Tsunoda I; Carlson NG
PLoS One; 2015; 10(4):e0123446. PubMed ID: 25885452
[TBL] [Abstract][Full Text] [Related]
3. [Paraneoplastic cerebellar degeneration associated with ovarian cancer: anti-Yo immunoreactivity in autoptic cerebellum and ovarian carcinoma].
Bartos A; Stourac P; Rusina R; Sejdová M; Velenská Z
Nervenarzt; 2002 Oct; 73(10):995-8. PubMed ID: 12376889
[TBL] [Abstract][Full Text] [Related]
4. Paraneoplastic cerebellar syndromes associated with antibodies against Purkinje cells.
Schwenkenbecher P; Chacko L; Pul R; Sühs KW; Wegner F; Wurster U; Stangel M; Skripuletz T
Int J Neurosci; 2018 Aug; 128(8):721-728. PubMed ID: 29199513
[TBL] [Abstract][Full Text] [Related]
5. Morphological and immunohistochemical characterization of paraneoplastic cerebellar degeneration associated with Yo antibodies.
Storstein A; Krossnes BK; Vedeler CA
Acta Neurol Scand; 2009 Jul; 120(1):64-7. PubMed ID: 19486326
[TBL] [Abstract][Full Text] [Related]
6. Anti-Yo antibody-mediated paraneoplastic cerebellar degeneration in a female patient with pleural malignant mesothelioma.
Tanriverdi O; Meydan N; Barutca S; Ozsan N; Gurel D; Veral A
Jpn J Clin Oncol; 2013 May; 43(5):563-8. PubMed ID: 23475537
[TBL] [Abstract][Full Text] [Related]
7. A case report of plasmapheresis treatment in a patient with paraneoplastic cerebellar degeneration and high anti-yo antibody titers.
Landtblom AM; Lindvall B; Ledin T; Berlin G
Ther Apher Dial; 2008 Feb; 12(1):82-5. PubMed ID: 18257818
[TBL] [Abstract][Full Text] [Related]
8. [Anti-Purkinje cell antibody (anti-Yo/type 1 antibody)].
Tanaka K
Nihon Rinsho; 2010 Jun; 68 Suppl 6():526-9. PubMed ID: 20942120
[No Abstract] [Full Text] [Related]
9. [Diagnostic tests: Anti-Purkinje cell antibody (Anti-Yo/type 1 antibody)].
Tanaka K
Nihon Rinsho; 2005 Jul; 63 Suppl 7():479-82. PubMed ID: 16111307
[No Abstract] [Full Text] [Related]
10. Atypical paraneoplastic syndrome associated with anti-Yo antibodies.
Finsterer J; Bodenteich A; Drlicek M
Clin Neuropathol; 2003; 22(3):137-40. PubMed ID: 12809356
[TBL] [Abstract][Full Text] [Related]
11. [Importance of plasmapheresis in the treatment of paraneoplastic cerebellar degeneration].
Basić-Jukić N; Kes P; Basić-Kes V; Brunetta B
Acta Med Croatica; 2004; 58(1):63-6. PubMed ID: 15125396
[TBL] [Abstract][Full Text] [Related]
12. Anti-Yo-associated paraneoplastic cerebellar degeneration in a man with gastric adenocarcinoma.
Meglic B; Graus F; Grad A
J Neurol Sci; 2001 Apr; 185(2):135-8. PubMed ID: 11311295
[TBL] [Abstract][Full Text] [Related]
13. Paraneoplastic gaze palsies in a patient with negative anti-Hu and anti-Yo antibody tests.
Okun MS; Bhatti MT; Eskin T; Eisenschenk S; Watson RT
South Med J; 2002 Dec; 95(12):1459. PubMed ID: 12597321
[No Abstract] [Full Text] [Related]
14. Antineuronal autoantibodies in paraneoplastic cerebellar degeneration associated with adenocarcinoma of the prostate.
Greenlee JE; Clawson SA; Hill KE; Dechet CB; Carlson NG
J Neurol Sci; 2010 Apr; 291(1-2):74-8. PubMed ID: 20089262
[TBL] [Abstract][Full Text] [Related]
15. [Anti-Yo antibody associated paraneoplastic cerebellar degeneration with gastric adenocarcinoma in a male patient: a case report].
Goto A; Kusumi M; Wakutani Y; Nakaso K; Kowa H; Nakashima K
Rinsho Shinkeigaku; 2006 Feb; 46(2):144-7. PubMed ID: 16619840
[TBL] [Abstract][Full Text] [Related]
16. Anti-Yo-associated paraneoplastic cerebellar degeneration in a man with adenocarcinoma of the gastroesophageal junction.
Debes JD; Lagarde SM; Hulsenboom E; Sillevis Smitt PA; ten Kate FJ; Sulter GA; van Lanschot JJ
Dig Surg; 2007; 24(5):395-7. PubMed ID: 17785986
[TBL] [Abstract][Full Text] [Related]
17. [Subacute paraneoplastic cerebellar degeneration with anti-neuronal antibodies and gynecological cancers. A case report of a bilateral ovarian cancer where the classic "anti-YO" antibody is associated with another antineuronal antibody].
Tremouilhac C; Hamy A; De Ferron E; Paineau J; Visset J
J Gynecol Obstet Biol Reprod (Paris); 1996; 25(3):253-6. PubMed ID: 8767221
[TBL] [Abstract][Full Text] [Related]
18. Carbonic anhydrase-related protein VIII antibodies and paraneoplastic cerebellar degeneration.
Höftberger R; Sabater L; Velasco F; Ciordia R; Dalmau J; Graus F
Neuropathol Appl Neurobiol; 2014 Aug; 40(5):650-3. PubMed ID: 24446689
[No Abstract] [Full Text] [Related]
19. Neurologic improvement after high-dose intravenous immunoglobulin therapy in patients with paraneoplastic cerebellar degeneration associated with anti-Purkinje cell antibody.
Phuphanich S; Brock C
J Neurooncol; 2007 Jan; 81(1):67-9. PubMed ID: 16773214
[TBL] [Abstract][Full Text] [Related]
20. [Neurologic paraneoplastic syndromes. Anti-Purkinje-cell-antibodies and anti-neuronal-nuclear-antibodies as serologic markers].
Altermatt HJ; Gerber HA; Scheithauer BW
Dtsch Med Wochenschr; 1993 Nov; 118(47):1735-41. PubMed ID: 8243252
[No Abstract] [Full Text] [Related]
[Next] [New Search]
